title: Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey.
abstract: BACKGROUND
  Few studies have analyzed factors that influence longitudinal changes in patient-perceived satisfaction during the recovery period following robot-assisted radical prostatectomy (RARP) for prostate cancer. We investigated variables that were associated with patient-perceived satisfaction after RARP using the expanded prostate cancer index composite (EPIC) survey.
  
  
  METHODS
  Of 175 men who underwent RARP between 2010 and 2011, 140 men completed the EPIC questionnaire preoperatively and 3, 6 and 12 months postoperatively. On the basis of the EPIC question no. 32 (item number 80), patients were divided into four groups according to the pattern of satisfaction change at postoperative 3 and 12 months: satisfied to satisfied (group 1); satisfied to dissatisfied (group 2); dissatisfied to satisfied (group 3); and dissatisfied to dissatisfied (group 4). Longitudinal changes in EPIC scores over time in each group and differences in EPIC scores of each domain subscale between groups at each follow-up were analyzed. A linear mixed model with generalized estimating equation approach was used to identify independent factors that influence overall satisfaction among repeated measures from same patients.
  
  
  RESULTS
  On the basis of the pattern of satisfaction change, groups 1, 2, 3 and 4 had 103 (74.3%), 21 (15.0%), 11 (7.9%) and 5 (2.9%) patients, respectively. The factor that was associated with overall satisfaction was urinary bother (UB) (β=0.283, 95% confidence interval (0.024, 0.543 ); P=0.033) adjusted for other factors under consideration.
  
  
  CONCLUSIONS
  UB was the independent factor influencing patient-perceived satisfaction after RARP. During post-RARP follow-up, physician should have the optimal management for the patient's UB.
authors.affiliation: 1] Section of Urologic Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA [2] Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea.
authors.forename: J H
authors.initials: JH
authors.lastname: Kim
authors.forename: Y-S
authors.initials: YS
authors.lastname: Ha
authors.forename: S J
authors.initials: SJ
authors.lastname: Jeong
authors.forename: S
authors.initials: S
authors.lastname: Kim
authors.forename: W-J
authors.initials: WJ
authors.lastname: Kim
authors.forename: T L
authors.initials: TL
authors.lastname: Jang
authors.forename: I Y
authors.initials: IY
authors.lastname: Kim
mesh_terms: D000328:Adult; D000368:Aged; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D010549:Personal Satisfaction; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods; D011471:Prostatic Neoplasms / Q000473:pathology / Q000523:psychology* / Q000601:surgery*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome
references.citation: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32
references.pmid: 18325680
references.citation: Urology. 2006 Nov;68(5):1061-6
references.pmid: 17113898
references.citation: Eur Urol. 2008 Oct;54(4):785-93
references.pmid: 18585849
references.citation: Urology. 1997 Apr;49(4A Suppl):66-76
references.pmid: 9111616
references.citation: J Urol. 2012 Dec;188(6):2213-8
references.pmid: 23083647
references.citation: Cancer. 2001 Jun 1;91(11):2046-55
references.pmid: 11391584
references.citation: J Clin Oncol. 2001 Mar 15;19(6):1619-28
references.pmid: 11250990
references.citation: BJU Int. 2012 Mar;109(6):898-905
references.pmid: 21933328
references.citation: Urology. 2009 Jan;73(1):119-23
references.pmid: 18952268
references.citation: Ann Fam Med. 2008 May-Jun;6(3):198-205
references.pmid: 18474881
references.citation: N Engl J Med. 2008 Mar 20;358(12):1250-61
references.pmid: 18354103
references.citation: Med Care. 1998 Jul;36(7):1002-12
references.pmid: 9674618
references.citation: Cancer Invest. 2007 Sep;25(6):449-57
references.pmid: 17882657
references.citation: J Urol. 2010 Oct;184(4):1309-15
references.pmid: 20723914
references.citation: Health Qual Life Outcomes. 2009 Nov 13;7:94
references.pmid: 19912640
references.citation: Urology. 2000 Dec 20;56(6):899-905
references.pmid: 11113727
references.citation: J Urol. 2008 May;179(5):1811-7; discussion 1817
references.pmid: 18353387
references.citation: BJU Int. 2011 Feb;107(4):585-90
references.pmid: 20804482
references.citation: J Urol. 2003 May;169(5):1653-61
references.pmid: 12686803
references.citation: Ann Intern Med. 2008 Mar 18;148(6):435-48
references.pmid: 18252677
references.citation: J Clin Oncol. 2003 Oct 15;21(20):3777-84
references.pmid: 14551296
references.citation: Eur Urol. 2011 May;59(5):702-7
references.pmid: 21296482
references.citation: J Clin Oncol. 2010 Nov 1;28(31):4687-96
references.pmid: 20921463
references.citation: Cancer. 2006 May 1;106(9):1865-74
references.pmid: 16568450